1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1)

Author：          

Publisher： Spandidos Publications

E-ISSN： 1791-3004|13|2|1373-1380

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.13, Iss.2, 2016-01, pp. : 1373-1380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling

By              

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2057-2066

Spandidos Publications

Access to resources Recommend Favorite

HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population

By                  

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2238-2250

Spandidos Publications

Access to resources Recommend Favorite

1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway

By          

Oncology Reports, Vol. 28, Iss. 6, 2012-01 ,pp. : 2131-2137

Spandidos Publications

Access to resources Recommend Favorite

p21WAF1/CIP1 Expression in breast cancers: associations with p53 and outcome

By Thor A.D.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 1, 2000-05 ,pp. : 33-43

Springer Publishing Company

Access to resources Recommend Favorite

Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo

By                      

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2449-2457

Spandidos Publications

Access to resources Recommend Favorite